About the Journal

ABOUT THE JOURNAL: Journal of Biopharmaceutics and Clinical Pharmacy publishes reviews and original articles, case studies, journal club drug interaction expositions etc.

The journal aims at prompting and promoting pharmacists in the healthcare (clinical pharmacists- community/hospital) to demonstrate knowledge and understanding of the application of therapeutics in their clinical practice.

This is achieved in the case study presentations, an integral part of Journal of Biopharmaceutics and Clinical Pharmacy (JBCP).

The underlying idea of publishing these case studies is therefore to meet the needs and challenges of modern pharmaceutical care as well as in postgraduate education.

The case studies will also help pharmacists to ensure patient safety and achieve desired health outcome through effective decision making.

The features will include:

  1. Respiratory System Case Studies
  2. Cardiovascular System Case Studies
  3. Chronic Obstruction Pulmonary Disease (COPD) with co-morbidity Case Studies
  4. Obstetrics and Gynaecology Case Studies
  5. Urinary Tract Infections (UTI) Case studies
  6. Liver Disease Case Studies
  7. Neurology Disease Case Studies
  8. Psychiatry Case Studies
  9. Cancer Case Studies
  10. Gastrointestinal Case Studies etc

JBCP is peer-reviewed and monthly published. It  presents cases in a systematic and interesting manner so that clinicians can replicates successful outcome.

Editorial staff of JBCP recommends that you consult the instructions to authors before proceeding with your submission. Editors have the rights reserved, to return manuscripts that do not meet these guidelines. There is no need to send paper copies of manuscripts by post or other means, if it has been submitted electronically. All articles are read by at least 2 reviewers and revision of articles may be required. Any returned article for revision must be submitted within 1 week of authors receiving the referee report.

The uniform requirements for manuscripts submitted to medical journals state that authorship credit should be based on substantial contribution to the following:

  1. Conception and design, acquisition of data, or analysis and interpretation of data.
  2. Drafting the article or revising it critically for important intellectual content
  3. Final approval of the version to be published.

All these three conditions must be met. Each author is expected to have participated sufficiently in the work to take responsibility for appropriate portions of the content.

Participation solely in the acquisition of funds, the collection of data or general supervision of the research group does not justify authorship. These categories of persons may be listed in the acknowledgement section. Every financial and material support should be acknowledged submissions to [email protected]

Instructions to authors

Title (not more than 14 words)

Abstract (not more than 100 words)

Medical history

Current complaint

Other diseases

Medications (natural product/dietary/herbal) taken.

Lifestyle, profession


Other relevant information

Pharmaceutical intervention (Possible Drug interactions etc)

Reasons/background (for each intervention)


Drug Audit

Dosing regimen

Method of administration

Onset of action

Possible side effect



Interaction with other products

Special warning/precaution


Typical Pharmaceutical Case Study



(Not more than 100 words)


(About 100-200 words)

Hypertension is a condition in which the force of the blood against the arterial wall is considered too high. Usually, hypertension is defined as blood pressure above 140/90, and is considered severe if the pressure is above 180/120. High blood pressure often has no symptoms. Over time if untreated, it can cause health onditions such as heart disease and stroke (Not more than 400 words)

Medical history

A 50 year-old woman, moderately overweight (BMI 28). Treated for hypertension for 15 years (Not more than 50 words).

Current compliant

Currently she has had several blood pressure elevations despite adhering to prescribed antihypertensive treatment. During these hypertensive urgency situations she has had moderate dull headache and felt tension. Due to family problems her life was stressful in the past 5 months. She claims her regular antihypertensive medications (see below) are tolerable(Not more than 100 words).

Other diseases


Medications (natural products, dietary/herbal supplement taken)


5/25 tablet (ramipril and hydrochlorothiazide; for one year).

One tablet every morning/day.

Cardilopin 5mg tablet (amlodipine; for one year) one tablet/day (evening).

Betaserc 8mg tablet (betahistine, for ten years) 2 x 2 tablets daily (morning and evening).


Valeriana relax capsules (Humulues, passiflora valeriana, for appox. 2 – 3 months)  capsule in the evening.


Non smoker patient and works in an office. She drinks some alcohol occasionally. She does physical activity regularly; walking or cycling for one hour, 3 to 4 times a week. She prefers low-fat foods and after eats fish (at least once a week).


No known allergies

Other relevant information

The patient has an automatic upper arm electronic/digital syphgmomanometer which she uses regularly. She used to smoke (4-5 sticks of cigarette daily) but quitted smoking a year ago (Not more than 50 words).

Pharmacist’s Intervention/Reasons and background

Decision on dispensing medication in the present case

The prescription only medicines were dispensed without any other OTC medicines.

Reasons/Background: There was no contraindication to dispense medication.

Valeriants Relax

It is not advisable to use the dietary supplement concomitantly with alprazolam

Reasons/Background: The new alprazolam medicine will resolve sleeping difficulties caused by stress. Accurately to interaction database (Lexi-Interact TM) dietary supplements containing valenan and passion flower may increase the sedative effects of alprazolam.

Prescription Drug Review

Meramyl HCT (2) conventional drugs review


  • Dosing regimen: One tablet in the morning.
  • Method of administration: The daily dose should be taken orally either before or after meal (meal does not affect bioavailability). The tablet should not be crushed or chewed.
  • Onset of action, not necessary. Patient started using drug long ago.
  • Possible side effect Common: Headache, weakness/fatigue, dizziness
  • Uncommon frequency: Angioedema, hypersensitivity.
  • Contraindications: No contraindications are relevant for the current patients.
  • Hypersensitivity to ramipril, other ACE inhibition thiazides or other sulphonamides.
  • Interaction with other medicinal products and other forms of interactions.


  • Concomitant use of potassium sparing diuretics, tacrolimus or cyclosporin increases the risk of hypernatremia – monitoring potassium level is needed.
  • Use of NSAIDS including ASA may reduce the antihypertensive effect of an ACEI. NSAIDS and ACEI may exert an additive effect on the increase in serum potassium levels and may result in deterioration of renal function.

Special warning and precautions for use – caution 20 mg lactulose per tablet.

Special precautions for storage, disposal and other handling. Do not store above 25oC.

Cardicopin (N) 5mg tabs (amlodipine 5mg) (same format)

Non-Pharmacological Advice

Blood pressure measurement

Electronic/digital sphygmomanometer should be validated each year. Comparison of digital/electronic with manual instrument occasionally is expedient.


Reduced salt intake, body weight reduction was discussed with the patient.


Regular blood pressure measurement with presence data/lime rewarding in a diary is recommended.

Seeking medical advice

In case of frequent hypertensive emergency, supervision of antihypertensive therapy is needed.

  • Call a doctor if systolic blood pressure is still high or symptoms are still present after taking the maximum dose of ACET.
  • In case of experiencing a strong headache, chest pain or dyspnoea during abnormal B.P elevation, call emergency.
  • Consult your doctor if you experience any sustained side effects after starting the newly prescribed medication.



Format for referencing is as in BIOSCIRD JOURNAL 


Manuscript should be written in clear, concise and grammatically correct English.

Headings: Headings should be in upper case and in bold type. Sub-headings should be in lower case and sub-subheadings should be in lower case and in italics.

Figures: A figure legend should be supplied (if figures are available, each on a separate page)

Tables: Number in order of mention in the text and Table should be in text form not shown as an image and each on a separate page.

References: Bibliographic references in the text appear like (John et al, 2019) References should be arranged alphabetically when listing.

Journal Club Presentations

 Title (Not more than 14 words)

Abstract  (Not more than 100 words)


(About 100-200 words)

Discussions Lead Issues

Questions and Answers (As contributions)

Key Points (Summarized as bullets)